Latest Funding News

West Cobar Metals has identified promising new copper, antimony, and silver targets at its Bulla Park project, supported by advanced geological and geophysical analysis. The company plans priority drilling to explore these zones and potentially expand its resource base.

Complii FinTech Solutions reported an 11.8% increase in customer receipts for Q4 FY25, alongside a 4.3% quarterly rise in annual recurring revenue, underscoring its expanding footprint in capital raising and compliance software.

Kula Gold Limited has reported impressive high-grade gold drilling results at its Mt Palmer Gold Mine, completing an 80% JV earn-in, while progressing exploration at Kirup and securing a niobium project approval in Malawi. The company faces a tight cash position but is actively managing funding.

Platinum Capital Limited has released detailed worked examples for its proposed scheme of arrangement, outlining a special dividend payout and the exchange ratio for shares into ETF units. The final dividend value and unit allocation will be confirmed closer to the scheme implementation date.

Platinum Asia Investments has released illustrative calculations for its Special Dividend and Scheme consideration tied to a proposed restructure, offering shareholders clarity ahead of a pivotal vote.

Rapid Critical Metals has completed its capital consolidation and placement, reshaping its issued capital structure with shareholder approval.

United Overseas Australia Ltd has signed a binding agreement to acquire a strategic land parcel in Ho Chi Minh City, aiming to develop a substantial commercial office building. The AU$104.7 million deal marks a significant expansion into Vietnam’s growing property market.

Imugene Limited has launched a $37.5 million equity raising through a Placement and Share Purchase Plan, offering new shares and options to fund its pivotal azer-cel clinical program. The raise includes attaching and piggyback options, subject to shareholder approval, aiming to bolster the company’s immuno-oncology pipeline.

Kinterra Capital has lodged a formal review application against the Takeovers Panel’s earlier ruling involving New World Resources, signaling potential shifts in the ongoing corporate governance saga.

Imugene Limited has launched a A$37.5 million capital raising to advance its promising off-the-shelf CAR T therapy, azer-cel, following encouraging Phase 1b data showing a 75% overall response rate in lymphoma patients.

Imugene Limited has completed a $22.5 million institutional placement and launched a $15 million Share Purchase Plan, both featuring attaching options, to fund its azer-cel clinical program through a pivotal trial in 2026.

Caspin Resources has completed the second tranche of its $2.1 million capital raising, issuing shares and free-attaching options approved by shareholders. The move strengthens funding for its diverse Australian mineral projects.